Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer

Hyun Ju Kim, Jee Suk Chang, Woong Sub Koom, Kyu Chan Lee, Gwi Eon Kim, Yongbae Kim

Research output: Contribution to journalArticle

Abstract

Objective: The feasibility of salvage radiotherapy (RT) for patients with recurrent cervical cancer after definitive treatment is contentious. The purpose of this study was to investigate the feasibility and benefit of RT, particularly intensity-modulated RT (IMRT), for salvage treatment in patients with recurrent cervical cancer. Methods: We retrospectively analyzed 125 patients with recurrent cervical cancer treated with RT at Yonsei Cancer Center between January 2007 and December 2016. All patients received salvage RT for the recurred or metastatic tumor mass. Irradiating dose and volume were determined depending on initial treatment. IMRT was selected in challenging cases, such as re-irradiation or for patients for whom implementing a satisfactory 3-dimensional conformal RT plan was challenging. Results: The median follow-up period was 5.5 years (range, 10.8 months to 41 years). The 5-year local failure-free survival (LFFS) and progression-free survival (PFS) rates were 63.9% and 39.6%, respectively. The 5-year overall survival (OS) rate was 66%; 10-year OS reached 51%. The median PFS rates in patients with locoregional failure, distant metastases, or both were 45.4, 29.1, and 14.7 months, respectively (p = 0.005). For the 45 patients that received re-irradiation, 5-year LFFS, PFS, and OS rates were 47.1%, 33.2%, and 66.5%, respectively. Late complications were observed in 12 patients (12/125, 9.6%). Conclusions: Our data suggest that salvage RT is safe and effective against recurrent cervical cancer. IMRT is a safe and effective salvage modality for these patients, including those requiring re-irradiation.

Original languageEnglish
Pages (from-to)208-214
Number of pages7
JournalGynecologic Oncology
Volume151
Issue number2
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Salvage Therapy
Uterine Cervical Neoplasms
Radiotherapy
Survival Rate
Disease-Free Survival
Conformal Radiotherapy
Intensity-Modulated Radiotherapy
Neoplasms
Neoplasm Metastasis
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Kim, Hyun Ju ; Chang, Jee Suk ; Koom, Woong Sub ; Lee, Kyu Chan ; Kim, Gwi Eon ; Kim, Yongbae. / Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer. In: Gynecologic Oncology. 2018 ; Vol. 151, No. 2. pp. 208-214.
@article{333f7c8a08d442db8b705c37eb0904f7,
title = "Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer",
abstract = "Objective: The feasibility of salvage radiotherapy (RT) for patients with recurrent cervical cancer after definitive treatment is contentious. The purpose of this study was to investigate the feasibility and benefit of RT, particularly intensity-modulated RT (IMRT), for salvage treatment in patients with recurrent cervical cancer. Methods: We retrospectively analyzed 125 patients with recurrent cervical cancer treated with RT at Yonsei Cancer Center between January 2007 and December 2016. All patients received salvage RT for the recurred or metastatic tumor mass. Irradiating dose and volume were determined depending on initial treatment. IMRT was selected in challenging cases, such as re-irradiation or for patients for whom implementing a satisfactory 3-dimensional conformal RT plan was challenging. Results: The median follow-up period was 5.5 years (range, 10.8 months to 41 years). The 5-year local failure-free survival (LFFS) and progression-free survival (PFS) rates were 63.9{\%} and 39.6{\%}, respectively. The 5-year overall survival (OS) rate was 66{\%}; 10-year OS reached 51{\%}. The median PFS rates in patients with locoregional failure, distant metastases, or both were 45.4, 29.1, and 14.7 months, respectively (p = 0.005). For the 45 patients that received re-irradiation, 5-year LFFS, PFS, and OS rates were 47.1{\%}, 33.2{\%}, and 66.5{\%}, respectively. Late complications were observed in 12 patients (12/125, 9.6{\%}). Conclusions: Our data suggest that salvage RT is safe and effective against recurrent cervical cancer. IMRT is a safe and effective salvage modality for these patients, including those requiring re-irradiation.",
author = "Kim, {Hyun Ju} and Chang, {Jee Suk} and Koom, {Woong Sub} and Lee, {Kyu Chan} and Kim, {Gwi Eon} and Yongbae Kim",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.ygyno.2018.08.029",
language = "English",
volume = "151",
pages = "208--214",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer. / Kim, Hyun Ju; Chang, Jee Suk; Koom, Woong Sub; Lee, Kyu Chan; Kim, Gwi Eon; Kim, Yongbae.

In: Gynecologic Oncology, Vol. 151, No. 2, 01.11.2018, p. 208-214.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer

AU - Kim, Hyun Ju

AU - Chang, Jee Suk

AU - Koom, Woong Sub

AU - Lee, Kyu Chan

AU - Kim, Gwi Eon

AU - Kim, Yongbae

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Objective: The feasibility of salvage radiotherapy (RT) for patients with recurrent cervical cancer after definitive treatment is contentious. The purpose of this study was to investigate the feasibility and benefit of RT, particularly intensity-modulated RT (IMRT), for salvage treatment in patients with recurrent cervical cancer. Methods: We retrospectively analyzed 125 patients with recurrent cervical cancer treated with RT at Yonsei Cancer Center between January 2007 and December 2016. All patients received salvage RT for the recurred or metastatic tumor mass. Irradiating dose and volume were determined depending on initial treatment. IMRT was selected in challenging cases, such as re-irradiation or for patients for whom implementing a satisfactory 3-dimensional conformal RT plan was challenging. Results: The median follow-up period was 5.5 years (range, 10.8 months to 41 years). The 5-year local failure-free survival (LFFS) and progression-free survival (PFS) rates were 63.9% and 39.6%, respectively. The 5-year overall survival (OS) rate was 66%; 10-year OS reached 51%. The median PFS rates in patients with locoregional failure, distant metastases, or both were 45.4, 29.1, and 14.7 months, respectively (p = 0.005). For the 45 patients that received re-irradiation, 5-year LFFS, PFS, and OS rates were 47.1%, 33.2%, and 66.5%, respectively. Late complications were observed in 12 patients (12/125, 9.6%). Conclusions: Our data suggest that salvage RT is safe and effective against recurrent cervical cancer. IMRT is a safe and effective salvage modality for these patients, including those requiring re-irradiation.

AB - Objective: The feasibility of salvage radiotherapy (RT) for patients with recurrent cervical cancer after definitive treatment is contentious. The purpose of this study was to investigate the feasibility and benefit of RT, particularly intensity-modulated RT (IMRT), for salvage treatment in patients with recurrent cervical cancer. Methods: We retrospectively analyzed 125 patients with recurrent cervical cancer treated with RT at Yonsei Cancer Center between January 2007 and December 2016. All patients received salvage RT for the recurred or metastatic tumor mass. Irradiating dose and volume were determined depending on initial treatment. IMRT was selected in challenging cases, such as re-irradiation or for patients for whom implementing a satisfactory 3-dimensional conformal RT plan was challenging. Results: The median follow-up period was 5.5 years (range, 10.8 months to 41 years). The 5-year local failure-free survival (LFFS) and progression-free survival (PFS) rates were 63.9% and 39.6%, respectively. The 5-year overall survival (OS) rate was 66%; 10-year OS reached 51%. The median PFS rates in patients with locoregional failure, distant metastases, or both were 45.4, 29.1, and 14.7 months, respectively (p = 0.005). For the 45 patients that received re-irradiation, 5-year LFFS, PFS, and OS rates were 47.1%, 33.2%, and 66.5%, respectively. Late complications were observed in 12 patients (12/125, 9.6%). Conclusions: Our data suggest that salvage RT is safe and effective against recurrent cervical cancer. IMRT is a safe and effective salvage modality for these patients, including those requiring re-irradiation.

UR - http://www.scopus.com/inward/record.url?scp=85052873936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052873936&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2018.08.029

DO - 10.1016/j.ygyno.2018.08.029

M3 - Article

VL - 151

SP - 208

EP - 214

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -